Now showing items 1-20 of 28
Title | Author(s) | Journal | Issue Date | Type |
---|---|---|---|---|
Substituting tenofovir for stavudine in resource-limited settings: there are challenges ahead [correspondence] | van Griensven, J.; Lynen, L.; Colebunders, R. | AIDS | 2009 | Letter |
HIV-1-infected individuals traveling to malaria endemic areas [letter] | Van geertruyden, J. P.; Colebunders, R.; D'Alessandro, U. | Journal of Acquired Immune Deficiency Syndromes | 2009 | Letter |
Impact of HIV-1 infection on the hematological recovery after clinical malaria | Van geertruyden, J. P.; Mulenga, M.; Chalwe, V.; Michael, N.; Moerman, F.; Mukwamataba, D.; Colebunders, R.; D'Alessandro, U. | Journal of Acquired Immune Deficiency Syndromes | 2009 | Article |
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching | Elliott, J. H.; Lynen, L.; Calmy, A.; De Luca, A.; Shafer, R. W.; Zolfo, M.; Clotet, B.; Huffam, S.; Boucher, C. A. B.; Cooper, D. A.; Schapiro, J. M. | AIDS | 2008 | Article |
Fever after a stay in the tropics: clinical spectrum and outcome in HIV-infected travelers and migrants | Bottieau, E.; Florence, E.; Clerinx, J.; Vlieghe, E.; Vekemans, M.; Moerman, F.; Lynen, L.; Colebunders, R.; Van Gompel, A.; Van den Ende, J. | Journal of Acquired Immune Deficiency Syndromes | 2008 | Article |
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial | Burman, W.; Grund, B.; Neuhaus, J.; Douglas, J.; Friedland, G.; Telzak, E.; Colebunders, R.; Paton, N.; Fisher, M.; Rietmeijer, C. | Journal of Acquired Immune Deficiency Syndromes | 2008 | Article |
Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy | Kamya, M. R.; Mayanja-Kizza, H.; Kambugu, A.; Bakeera-Kitaka, S.; Semitala, F.; Mwebaze-Songa, P.; Castelnuovo, B.; Schaefer, P.; Spacek, L. A.; Gasasira, A. F.; Katabira, E.; Colebunders, R.; Quinn, T. C.; Ronald, A.; Thomas, D. L.; Kekitiinwa, A. | Journal of Acquired Immune Deficiency Syndromes | 2007 | Article |
When to switch for antiretroviral treatment failure in resource-limited settings? [editorial] | Vekemans, M.; John, L.; Colebunders, R. | AIDS | 2007 | Editorial |
The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia | Lynen, L.; Thai, S.; De Munter, P.; Leang, B.; Sokkab, A.; Schrooten, W.; Huyst, V.; Kestens, L.; Jacques, G.; Colebunders, R.; Menten, J.; Van den Ende, J. | Journal of Acquired Immune Deficiency Syndromes | 2006 | Article |
Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble Gag protein in HIV-infected subjects | Tavernier, A.; Jennes, W.; Fransen, K.; De Roo, A.; Kestens, L. | Journal of Acquired Immune Deficiency Syndromes | 2006 | Article |
Unexpected improvement of sexual dysfunction during atazanavir therapy [letter] | Colebunders, R.; Moerman, F.; Nöstlinger, C. | AIDS | 2006 | Letter |
CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria | Van geertruyden, J. P.; Mulenga, M.; Kasongo, W.; Polman, K.; Colebunders, R.; Kestens, L.; D'Alessandro, U. | Journal of Acquired Immune Deficiency Syndromes | 2006 | Article |
Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia | Lynen, L.; Teav, S.; Vereecken, C.; De Munter, P.; An, S.; Jacques, G.; Kestens, L. | Journal of Acquired Immune Deficiency Syndromes | 2006 | Article |
The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk [research letter] | Colebunders, R.; Hodossy, B.; Burger, D.; Daems, T.; Roelens, K.; Coppens, M.; Van Bulck, B.; Jacquemyn, Y.; Van Wijngaerden, E.; Fransen, K. | AIDS | 2005 | Article |
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time | Ariën, K. K.; Troyer, R. M.; Gali, Y.; Colebunders, R.; Arts, E. J.; Vanham, G. | AIDS | 2005 | Article |
Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005 [reply] | John, L.; Baalwa, J.; Kalimugogo, P.; Nabankema, E.; Castelnuovo, B.; Muhindo, G.; Colebunders, R.; Kambugu, A. | AIDS | 2005 | Letter |
Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients [letter] | Callens, S.; Bottieau, E.; Michielsen, P.; Colebunders, R. | AIDS | 2004 | Letter |
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response [letter] | Derdelinckx, I.; Van Laethem, K.; Maes, B.; Schrooten, Y.; De Wit, S.; Florence, E.; Fransen, K.; García Ribas, S.; Marissens, D.; Moutschen, M.; Vaira, D.; Zissis, G.; Van Ranst, M.; Van Wijngaerden, E.; Vandamme, A. M. | Journal of Acquired Immune Deficiency Syndromes | 2004 | Letter |
Role of baseline pol genotype in HIV-1 fitness evolution | Weber, J.; Rangel, H. R.; Chakraborty, B.; Marotta, M. L.; Valdez, H.; Fransen, K.; Florence, E.; Connick, E.; Smith, K. Y.; Colebunders, R. L.; Landay, A.; Kuritzkes, D. R.; Lederman, M. M.; Vanham, G.; Quiñones-Mateu, M. E. | Journal of Acquired Immune Deficiency Syndromes | 2003 | Article |
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited | Moore, A. L.; Kirk, O.; Johnson, A. M.; Katlama, C.; Blaxhult, A.; Dietrich, M.; Colebunders, R.; Chiesi, A.; Lungren, J. D.; Phillips, A. N. | Journal of Acquired Immune Deficiency Syndromes | 2003 | Article |
Now showing items 1-20 of 28